Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

REGN Stockholders Interested in Leading the Class Action Against Regeneron Pharmaceuticals, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses - PR Newswire

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Why pharmaceutical companies are interested in psychedelics - marketplace.org

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Arrowhead Pharmaceuticals (ARWR) Advances REDEMPLO Launch, Is The Stock Still Undervalued? - simplywall.st

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals - GlobeNewswire

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Amylyx Pharmaceuticals Prices 14.09M-Share Public Offering at $35.50; Nets ~$472M - TradingView

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Mitochon Pharmaceuticals Announces $1 Million Award From ALS Association for Phase II Clinical Study - Business Wire

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

FDA Approves Pasatru | PharmExec - Pharmaceutical Executive

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Regeneron Pharmaceuticals, Inc. (REGN) Investors: September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - PR Newswire

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Non-Profit Pharmaceutical Manufacturer Delivers Drug Access to Rural Hospitals - The Daily Yonder

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

REGENERNON PHARMACEUTICALS, INC. (REGN) SHAREHOLDER ALERT - GlobeNewswire

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Telix Pharmaceuticals: Strong Revenue Growth, With Upcoming Resubmission for Zircaix - Morningstar

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Shannon Kelley Sells 664 Shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock - MarketBeat

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Regeneron Pharmaceuticals (REGN) Wins FDA Approval For The First Adult FOP Treatment - simplywall.st

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug - Benzinga

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule - TradingView

news.google.com · 21 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Technology transforms health human resources management - hospitalnews.com

SPARSH Hospitals Appoints Kalappa K.B. as Group Chief Human Resources Officer - hrtoday.in

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Early Alert: Portrait Core Services Software Issue from GE HealthCare

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

BBC Inside Science

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

REGN Stockholders Interested in Leading the Class Action Against Regeneron Pharmaceuticals, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses - PR Newswire

Why pharmaceutical companies are interested in psychedelics - marketplace.org

Arrowhead Pharmaceuticals (ARWR) Advances REDEMPLO Launch, Is The Stock Still Undervalued? - simplywall.st

Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals - GlobeNewswire

Amylyx Pharmaceuticals Prices 14.09M-Share Public Offering at $35.50; Nets ~$472M - TradingView

Mitochon Pharmaceuticals Announces $1 Million Award From ALS Association for Phase II Clinical Study - Business Wire

FDA Approves Pasatru | PharmExec - Pharmaceutical Executive

Regeneron Pharmaceuticals, Inc. (REGN) Investors: September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - PR Newswire

Non-Profit Pharmaceutical Manufacturer Delivers Drug Access to Rural Hospitals - The Daily Yonder

REGENERNON PHARMACEUTICALS, INC. (REGN) SHAREHOLDER ALERT - GlobeNewswire

Telix Pharmaceuticals: Strong Revenue Growth, With Upcoming Resubmission for Zircaix - Morningstar

Shannon Kelley Sells 664 Shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock - MarketBeat

Regeneron Pharmaceuticals (REGN) Wins FDA Approval For The First Adult FOP Treatment - simplywall.st

Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug - Benzinga

Madrigal Pharmaceuticals Announces Grants Of Inducement Awards Under Nasdaq Listing Rule - TradingView